About LinXis
LinXis develops targeted therapeutics for the treatment of fibrosis. The basis of these therapeutics are Fibrobodies®: Small recombinant antibody-like proteins that can shuttle potent small molecules to the activated fibroblasts that are center to the disease.
Our small but multi-disciplinary team is fully self-supporting. Our activities span from early research and development to preclinical and clinical evaluation. Our team comprises organic (radio-) chemists, molecular biologists, biochemists, biotechnologists, and CMC specialists. Our employees are embedded in top-notch laboratories in the Amsterdam UMC (the newly opened Amsterdam UMC Imaging Center) and Utrecht University (Department of Cell Biology).
Our employees are highly motivated and have a strong sense of responsibility. In return, we offer a high degree of freedom in a very dynamic team.
We are currently pushing our lead Fibrobody towards clinical validation in various forms of fibrosis. At the same time, we are diversifying our platform by developing novel Fibrobodies against other potential targets. In this context we are looking for a Conjugation Chemistry Technician.